Immunotherapy is changing the landscape of cancer treatment. Whether on its own or in conjunction with other therapies, immunotherapy gives patients’ bodies the tools they need to destroy cancer cells. Each disease has unique markers that must be identified for a targeted treatment to be developed. Once researchers get on the right track, the results are increasingly promising. Researchers at the Memorial Sloan Kettering Cancer Center are working with mesothelioma patients as part of an ongoing clinical trial of a novel immunotherapy-radiation therapy combination.
The trial opened in early 2018 for both pleural mesothelioma and peritoneal mesothelioma patients. Both the targeted radiation therapy and new immunotherapy drug, Avelumab, have shown success on their own, and the investigators are hopeful that they will be even more effective together.
Combination Treatment Delivers Multiple Boosts to Immune System
Mesothelioma tumor cells produce a PD-L1 protein, which helps them avoid detection by the patient’s immune system. Avelumab helps the immune system target PD-L1 and destroys the cancerous cells. Avelumab has proven effective in combating several cancers, including mesothelioma; in its most recent trial, the drug halted the progression of tumors on an average of 17.1 weeks after treatment and reduced the size of tumors in 10 percent of the patients.
While there are currently multiple active trials around the world involving Avelumab, researchers at the Memorial Sloan Kettering Cancer Center are pairing the drug with targeted radiation. Radiation significantly reduces the risk of recurrence with many types of cancers, acting as a vaccine to prevent additional tumors from developing.
Stereotactic Body Radiation Therapy
Stereotactic body radiation therapy (SBRT), a high-dose form of radiation with remarkable accuracy, has proven effective in combating mesothelioma, giving patients an immune boost to help fight the disease. In this trial, patients will receive a dose of Avelumab every two weeks and regular SBRT treatments. Given the immune boosting power of each, researchers are hopeful that they will work well with each other.
The Clinical Trial
The trial is scheduled to conclude in 2020, so this combination therapy is not available to patients yet, but a successful trial would be a significant advance in the treatment of mesothelioma. To be eligible to participate in the trial, a potential candidate must meet the following criteria:
Candidate must be over the age of 18
Candidate had no prior immunotherapy treatments
A candidate must have recovered from the serious side effects of any prior therapy
The candidate must have recurrent or persistent malignant pleural or peritoneal mesothelioma that grew or returned after a treatment that included pemetrexed and a platinum-containing drug
Mesothelioma, which is caused by exposure to asbestos, is a rare and fatal cancer that impacts the lining of the lungs, heart, and chest cavity. It is notoriously resistant to common cancer treatments, leaving patients with few options for recovery.
Philadelphia Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Advocate for Victims of Asbestos Exposure
If you or a loved one has been diagnosed with mesothelioma or another asbestos-related disease, call the Philadelphia mesothelioma lawyers at Brookman, Rosenberg, Brown & Sandler. Our knowledgeable, experienced legal team will fight to obtain the compensation you are entitled. Call us today for a free consultation at 215-569-4000 or contact us online. Located in Philadelphia, we serve clients in Delaware County, Chester County, Philadelphia County, and throughout Pennsylvania and New Jersey.
Information is power, and more and more people receive the bulk of their information from social media. Mesothelioma researchers are using social media to inform people exposed to asbestos about their risks, as well as to let those already diagnosed with the disease know about clinical trials and new treatment options.
There is also hope that as more people become aware of mesothelioma and various treatments, the odds of finding a cure rise.
Boosting the Survival Rate
Disseminating more information about mesothelioma to those exposed to asbestos or diagnosed with this rare cancer may help improve survival rates. Already, many patients stricken with mesothelioma are living longer than the typical survival time of two years after diagnosis.
More information about mesothelioma symptoms can lead to earlier diagnosis, which also improves survival rates.
Perhaps the most critical use of social media for mesothelioma victims is the spread of information regarding clinical trials to eligible patients. Nationwide, less than 5 percent of those diagnosed with any form of cancer participate in a clinical trial for new drugs or therapies. Because the number of people diagnosed with mesothelioma is relatively small, mesothelioma trials are most often done using data collection, not actual patients.
With social media, mesothelioma researchers want to reach more patients who may qualify for clinical trials. Many patients do not reside in the larger metropolitan areas where such trials are generally conducted, and will not hear about these opportunities from their local oncologists. However, a social media campaign to spread the word about clinical trials for mesothelioma allows these patients to learn about the trials and look into whether they are eligible.
Finding the Right Social Media Platform
Getting the mesothelioma message out on social media involves identifying the right target audience and choosing the platforms that the audience is most likely to use. Very few patients are diagnosed before age 50, and the average age at diagnosis is 69.
That also means it makes little sense to target mesothelioma information on platforms such as Twitter or Instagram, since most users of these platforms are millennials. Facebook, however, trends older, and as such is the social media platform used most often by an older demographic.
Not only are those vulnerable to the disease or already diagnosed with it more likely to use Facebook, but so are their contemporaries, who may view the information and pass it on to friends or relatives affected by mesothelioma. Facebook is by far the most used social media platform.
Philadelphia Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Help Those Diagnosed with Mesothelioma
Mesotheliomais a particularly difficult to treat cancer that develops from exposure to asbestos. While a recent discovery does not offer a new avenue to a cure, it does offer potential new insight into diagnosis, staging, and treatment options for this terrible disease.
Clinical Trial Discovers Posterior Intercostal Lymph Nodes Link
Fifty-six mesothelioma patients were part of a recent clinical trial at the University of Maryland. While the clinical trial was designed to determine the impact of lung sparing surgery on patients, the doctors conducting the trial discovered that almost half of the patients had cancer in their posterior intercostal lymph nodes. These lymph nodes are located near the spine, between the ribs.
Previously, doctors used the mediastinal lymph nodes, located in the chest between the spinal column and sternum, for cancer staging and treatment choices. According to the Charles Reid Edwards Professor of Surgery and Head of the Division of Thoracic Surgery at the University of Maryland School of Medicine (UMSOM), the posterior intercostal lymph nodes could turn out to be as important, or more so, than any other lymph nodes included in the staging of pleural mesothelioma.
Evidence of Metastasis
Cancer cells from solid tumors spread throughout the body via metastasis, and the route for many such cells is the lymph nodes. The study revealed that 11 percent of the patients had mesothelioma spreading only through the intercostal lymph nodes. Previously, these nodes would not have been removed or even biopsied for determining a cancer’s stage.
As noted, including the 11 percent of patients who had evidence of mesothelioma only in these nodes, approximately half of the patients had mesothelioma in these and other lymph nodes. Those whose cancer had metastasized to the intercostal nodes had a 2.5 times greater likelihood of tumor progression and 2.3 times “elevated risk of death.”
While involvement of the intercostal lymph nodes appears to mean an even worse prognosis for mesothelioma patients, as it shows a spreading of the cancer, there is something of a silver lining. Cancer surgery is difficult and debilitating, and the discovery of intercostal lymph node involvement means some patients may not receive such complicated and aggressive surgery.
If the cancer has already metastasized, performing very aggressive surgery does not make sense, as it is unlikely to increase the patient’s life span, and the difficult recuperation may lead to an earlier death. Instead, doctors can focus on the quality of life in patients with cancer cells in their intercostal lymph nodes.
The information from this study indicates mesothelioma surgeons should include performing biopsies on the intercostal lymph nodes on all patients, and the UMSOM thoracic surgeon says that such node biopsies should become part of the cancer staging process.
Philadelphia Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Help Those Dealing with Mesothelioma Treatment Options
Mesothelioma is a cancer the affects the lining of the lungs, abdomen, and other organs, and is caused by exposure to asbestos. This disease has no cure, though new treatments are being developed constantly.
Mesothelioma sufferers have fought for the implementation of a National Mesothelioma Patient Registry for years. According to recent news, this may finally become a reality.
The Centers for Disease Control and Prevention (CDC) is funding a study to determine the practicality of a mesothelioma patient registry. The funding originates from Congress’ allocation of $1.2 million dollars for the purpose of mesothelioma research.
The National Institute for Occupational Safety and Health (NIOSH) is responsible for conducting the $100,000 feasibility study. The study will primarily indicate if implementing a National Mesothelioma Patient Registry is viable. The NIOSH is a federal agency known for conducting research in order to make recommendations on behalf of employee health and safety.
What Is a Patient Registry?
A patient registry is defined as a collection of data focusing on patients that suffer from a similar disease, exposure, or condition. Registries often collect health information from individuals in order to find trends and expand knowledge about a certain condition.
Some of the health information patient registrars will collect include a patient’s demographic, basic health information, or their health history. Despite its simplistic nature, uncovering this data is crucial to learning more about mesothelioma and potentially discovering new treatments.
Why Are Patient Registries Important?
Patient registries are helpful tools that assist researchers to develop treatment options, gauge a better understanding of a disease, and work toward finding a cure. Clinical study designs may be improved by registries, due to an increased knowledge of patient health trends.
Patient registries also have the potential to help researchers create new hypotheses that may lead to new discoveries about the exposure, disease, or condition. Patients may also have more opportunities to participate in clinical trials.
Registries for Other Diseases
Other diseases have found promising results after the implementation of a patient registry, including diseases like Gaucher’s disease and muscular dystrophy.
The director of the Respiratory Health Division of NIOSH claims that enacting a mesothelioma patient registry allows patients to find available treatments, services, and clinical trials that may allow for a prolonged survival rate. Ultimately, patient registries have the potential to help save lives.
According to The Mesothelioma Center, approximately 45,000 Americans died from mesothelioma between 1999 and 2015. Although this statistic may be startling, the number continues to grow.
Victims of mesothelioma have fought for the opportunity to develop a patient registry for years. Implementing a National Mesothelioma Patient Registry has the potential to help researchers work toward finding a cure.
New Jersey Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Represent Patients Suffering from Mesothelioma
Being diagnosed with Mesothelioma can evoke feelings of despair, hopelessness, and fear, but no one needs to suffer alone. Contact a New Jersey mesothelioma lawyer at Brookman, Rosenberg, Brown, & Sandler. Our lawyers show compassion throughout the process, and are willing to fight for the compensation our clients deserve. Contact us online or call 215-569-4000 for a free consultation. With offices located in Philadelphia, we proudly serve clients in Delaware County, Chester County, Philadelphia County, and throughout Pennsylvania and New Jersey.
On February 19, 2019, five groups filed suit against the Environmental Protection Agency (EPA) to challenge the EPA’s decision permitting exemptions in rules for asbestos reporting.
In addition, the organizations criticized the agency’s petition denial of a plan to ramp up reporting requirements for those companies dealing with asbestos. Their complaints state that most scientists agree that there is no safe level of asbestos exposure.
The five organizations involved in the suit include the Asbestos Disease Awareness Organization (ADAO), the Center for Environmental Health, the Environmental Working Group, the American Public Health Association, and the Environmental Health Strategy Center.
A Well-Established Carcinogen
While those exposed to asbestos are more likely to develop mesothelioma, a rare cancer targeting the tissues lining the lungs, abdomen, and other organs, since the 1970s asbestos exposure has been linked to increased risk of cancer of the larynx and ovaries as well.
In 1989, the EPA actually banned the material, but two years later the Fifth Circuit Court of Appeals overturned the asbestos ban.
Asbestos Reporting Loophole
Among the issues addressed in the lawsuit is the EPA’s Chemical Data Reporting rule, which requires companies to report the amount of asbestos in their products. However, in 2017, the EPA exempted Occidental Chemical Corporation from reporting asbestos levels in their products because the amount of asbestos was “naturally occurring.”
The company is the largest asbestos importer in the United States, and the plaintiffs allege that it has failed to notify the EPA about the total amount of asbestos imported.
In 2018, a petition was filed under section 21 of the Toxic Substances Control Act (TSCA), requesting that the EPA eliminate the naturally occurring loophole. But the EPA denied the petition on the basis that strengthening reporting regulations would not produce information of which the EPA was unaware.
In response, this new lawsuit disputes the EPA’s claim, citing the discovery of asbestos in products as varied as makeup, baby powder and crayons. The ADAO states that nearly 40,000 Americans die each year from asbestos-related diseases.
Among other issues, the lawsuit seeks a declaration from the EPA that asbestos poses an unreasonable human health risk. Further, they want the court to order the agency to begin a new rulemaking process for reporting asbestos.
State Attorneys General Petition
Environmental and health organizations are not the only ones filing petitions regarding the EPA. In late January, Attorneys General from 14 states and the District of Columbia also filed a petition under the TSCA, requiring that information regarding asbestos importation, use, and exposure, be reported.
New Jersey Asbestos Attorneys at Brookman, Rosenberg, Brown & Sandler Fight for Those Exposed to Asbestos
The New Jersey asbestos attorneys at Brookman, Rosenberg, Brown & Sandler provide experienced and supportive legal representation for those who have become ill from exposure to asbestos. We know what is needed to get the compensation victims require while fighting this terrible disease. We serve clients in New Jersey as well as Pennsylvania, including Philadelphia, Philadelphia County, Chester County and Delaware County. Contact us for a free case evaluation by calling 265-569-4000 or by completing our online form.
Asbestosis a known cancer-causing substance with no safe level of exposure. Yet this dangerous substance is still used in the United States. Recently, a coalition of sixteen U.S. attorneys general filed a petition advocating for a new federal rule that would significantly increase asbestos reporting and better protect public health.
Despite its known carcinogenic effects, asbestos is currently categorized as exempt under the Environmental Protection Agency’s (EPA) Chemical Data Reporting Rule.
A Naturally Occurring Substance
Asbestos is treated under the rule as eligible for exemptions because it is a naturally occurring substance derived from a mineral. Yet every year more than 15,000 Americans die from complications of exposure to this documented carcinogen.
Because of its insulating and fireproofing properties, asbestos was widely used in numerous industries from shipbuilding and automobiles to the military and home and commercial construction up until the early 1980’s.
Pennsylvania has the third-highest fatality rate in the nation from asbestos exposure related illnesses. The most infamous is arguably Mesothelioma, a deadly disease that presently has no cure and is the result of inhalation of asbestos fibers.
It has been known for more than 70 years that asbestos exposure causes mesothelioma, various cancers and other diseases. As a result, it began to be regulated starting in the 1970’s.
However, the United States is not one of the more than 60 nations that have banned asbestos, despite the hazards, and even still allows it for certain uses.
State Attorneys General Taking Action
In 2016 the EPA had begun revamping of the Toxic Substances Reporting Act (TSRA), to better review a list of ten toxic substances, including asbestos. However, in 2018 the EPA under the Trump administration introduced a new rule that the attorneys general argue has the effect of allowing more, not fewer, uses of asbestos.
The coalition of attorneys general argue in their petition that the EPA cannot fully comply with the TSRA, because the exemption exists and allows certain uses for asbestos. They also argue that asbestos processors and manufacturers should be required to comply with reporting requirements and that this should include asbestos importers.
The coalition states that the EPA is not gathering the required data on importing and processing of asbestos-containing items, and thus cannot fully assess and regulate the health hazards.
The coalition is led by the attorneys general of California and Massachusetts and includes Connecticut, Minnesota, Hawaii, Maryland, New York, New Jersey, Pennsylvania, Oregon, Vermont, Washington, Rhode Island, and the District of Columbia.
Mesothelioma from Asbestos Exposure
Mesothelioma is challenging to treat and is difficult to initially diagnose when it is in the early stages and most treatable. It primarily affects the lining of the lungs, heart, and other organs. Those who worked in industries with asbestos, such as mining and shipbuilding, are at highest risk of developing the fatal illness.
If you or a loved one believes you have been exposed to asbestos in the home, workplace, or military service, the guidance of an experienced Pennsylvania asbestos lawyer is critical to receiving the care and compensation you need.
Asbestos Lawyers in Pennsylvania at Brookman, Rosenberg, Brown & Sandler Will Advocate for Your Asbestos Exposure Case
No one ever wants to here those three horrible words, “you have cancer.” But with prognoses varying so greatly from cancer to cancer, understanding the survival rate of the cancer which you have been diagnosed with can help to set goals and establish expectations.
Mesothelioma is a cancer that occurs due to exposure to asbestos. It affects the lining of the lungs and other internal organs, and unfortunately has no cure.
Early Diagnosis Proves Difficult
For those diagnosed with mesothelioma, the prognosis is often very poor. This is because people with mesothelioma are generally diagnosed in the later stages of the disease, after it has already spread.
This is due in part because the initial symptoms of the disease present as other illnesses, and it tends not to develop until many years after the asbestos exposure occurred.
About 55 percent of those with mesothelioma live longer than six months, and 35 percent will live longer than one year; but only 9 percent will live longer than five years. Much of these survival rates will depend upon the patient’s age and gender. Younger patients and women tend to have a better prognosis.
Other factors influencing survival rates include:
Blood counts: Those with high levels of white blood cells, platelets, or low hemoglobin negatively impact survival rates.
Cell type: Epithelioid mesothelioma usually has the highest rate of survival, followed by biphasic mesothelioma and sarcomatoid mesothelioma respectively.
Genetics: The biomarker BRCA1 gene being present has demonstrated a correlation to longer survival rates.
Lifestyle Factors: Non-smokers have a better prognosis than smokers generally do.
Overall health: Those in better health generally have an improved prognosis than those suffering from poor health factors, including a compromised immune system or obesity.
Despite the bleak outlook from such a diagnosis, there are still some stories of survival. Treatment, in particular treatment as early as possible, is the most important factor in terms of lengthening one’s survival rate.
Seeking Medical Attention
One of the best things that you can do for yourself is to see a doctor if you have been around asbestos or diagnosed with exposure to it in the past. Quick action can save lives. The earlier a diagnosis has been established, the higher one’s odds are for survival. Earlier treatments help to slow growth of and potentially eliminate tumors all together.
Unlike pleural mesothelioma, peritoneal mesothelioma has a higher survival rate for many patients. Newer treatments such as heated intraperitoneal chemotherapy (HIPEC) has increased patient survival rates, with 5-year peritoneal mesothelioma survival rates improving up to at least 50 percent.
Often clinical trials are a good idea for improving one’s prognosis. Aside from HIPEC, treatments such as immunotherapy are demonstrating potentially hopeful outcomes.
Philadelphia Mesothelioma Attorneys at Brookman, Rosenberg, Brown & Sandler Help Those Who Have Been Diagnosed with Mesothelioma
If you or a loved one is suffering from mesothelioma, you deserve an attorney who will fight for what it is that you deserve. The Philadelphia mesothelioma attorneys at Brookman, Rosenberg, Brown & Sandler have experience helping victims of mesothelioma throughout the Greater Philadelphia and South Jersey areas. From Delaware County to Chester County to Philadelphia County, we fight for our clients across Pennsylvania. For a free consultation or to learn more, contact us online or call us at 215-569-4000 today.
Recent studies indicate the effectiveness of a potential new treatment option for mesothelioma patients. According to research, when patients received a combination of chemotherapy treatments and TroVax, immune responses were boosted. The study results indicate a potential new option for those suffering from this aggressive cancer.
What is TroVax?
TroVax is a cancer vaccine that helps eliminate excess amounts of a protein called 5T4. High levels of 5T4 are often found in patients suffering from tumors. The virus engineered into the vaccine alerts the immune system to make antibodies that kill 5T4, which ultimately keeps the tumor from spreading.
Some patients have even had their tumors shrink in size. Unlike other vaccinations, patients will need to have the vaccine injected every few months to see results.
TroVax is being used in clinical studies for several different types of cancer, including colorectal cancer, kidney cancer, and ovarian cancer.
Clinical Study Results
When used in a clinical study, the combination of TroVax and chemotherapy treatments has produced potentially encouraging results for those struggling with mesothelioma. The study was handled by researchers from Cardiff University in the United Kingdom.
Despite having 27 participants in the study, only 23 of the participants received at least one round of chemotherapy and three doses of the cancer vaccine. Yet the results of the combination were encouraging.
Findings showed that over 95 percent of the 23 participants developed an increased immune response after the treatments. Better yet, more than 17 percent of participants had tumor shrinkage.
Overall, the combination of the vaccination and chemotherapy treatments allowed for a longer survival period and increased disease control. According to the study results, the median time it took for the tumors to begin growing again was 6.8 months.
The Future of Cancer Vaccines
The implementation of cancer vaccines attracts skeptics; yet this approach to cancer eradication is showing hopeful results. Cancer vaccines differ from regular vaccines – instead of administering them to prevent sickness, cancer vaccines are designed to strengthen the patient’s immune responses after they have been diagnosed with the disease.
Strengthening the immune responses helps to destroy the cancer cells in the patient’s body, which ultimately helps with disease control.
Studies are still being implemented to fully understand the role of cancer vaccines in a patient’s regimen. Although previous cancer vaccines have failed, they allowed for an increased understanding about how vaccines work to fight cancer.
Scientists discovered that vaccines are best used in conjunction with other treatments in order to avoid cancer cell mutation.
Pennsylvania Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Can Help You with Your Mesothelioma Case
If you or someone you know has been diagnosed with mesothelioma due to asbestos exposure, please consider contacting a Pennsylvania mesothelioma lawyer at Brookman, Rosenberg, Brown & Sandler. A mesothelioma diagnosis may invoke feelings of fear or hopelessness. Our lawyers work closely with clients and display compassion throughout the process. Contact us online or call 215-569-4000 for a free consultation. Our lawyers proudly serve clients in multiple convenient areas, including Delaware County, Chester County, and Philadelphia County, Pennsylvania, and throughout New Jersey.
The idea that cancer treatment should be available and prescribed based on a patient’s particular medical needs, and not marital status, seems obvious. Yet bias in favor of married people can affect the type and aggressiveness of treatment that patients receive, according to one recent study that should ring alarm bells for patients.
Mesothelioma patients, like all cancer patients, come from a myriad of demographics: married, divorced, widowed, single; and of different races, religions, and sexual orientations, among other characteristics. Why then would a cancer patient’s marital status have anything to do with the type of care they receive?
One researcher believes that inherent bias and overgeneralization by medical practitioners can affect how they view patients, and thus the type of care they recommend.
Asbestos and Mesothelioma
Mesothelioma is caused by exposure to asbestos. Asbestos is a naturally occurring substance classified as a carcinogen in the United States, and was used in insulation and fireproofing applications for many years. When it breaks down, inhaling asbestos fibers can produce mesothelioma, which is a cancer affecting the lining of the lungs and other organs. Those who were exposed to asbestos in the workplace often do not see development of symptoms until decades after the exposure.
While mesothelioma cannot be cured, there are chemotherapies, immunotherapies, radiation, surgery, and other treatments available. More is forthcoming, as ongoing research and development strives to provide new options for patients.
Research into Cancer Treatment for Singles
A recent Washington Post piece highlighted a case where the writer herself realized a difference in recommended cancer treatment, based on her single status. The writer happened to also be a skilled researcher, and so to test the theory, turned to the National Cancer Institute’s extensive research studies.
Her findings from a database review showed that single patients did, in fact, have major differences in treatment. Her own experience led her to pursue more aggressive treatment with another oncologist. But the findings showed that she was not unique in noticing that single patients are treated differently than married patients.
Study Findings and Recommendations
In one prominent oncology journal, more than three-quarters of a million patients with cancer were studied. The journal article associated single status with depression, lack of social supports, and medical noncompliance – despite the lack of hard statistical data comparing single adults with others in the U.S. population.
It also did not show a scientific reason to generalize that this profile might fit over 110 million single adults. Other studies showed similar perceived bias, and indicated that an inherent bias in the medical field can leave unmarried cancer patients at a serious disadvantage.
Recommendations include that the medical community recognize that while marriage conveys a type of security and support not available to single adults, this is a conventional but not statistically true idea. Recognizing bias in medical treatment, whether on the basis of family status, age, economic status, or other factors, is critical for medical practitioners to be able to provide the best care possible.
It also means that patients as consumers of the medical industry must always explore alternatives and second opinions if they believe they are not getting appropriate care.
Philadelphia Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Have the Experience Mesothelioma Patients Need
Caregivers are key people for anyone undergoing treatment for a serious illness like mesothelioma. Caregivers are those family members, partners, and friends who provide support, as well as emotional and practical help, to the person who is being treated for cancer.
Those who have done this know that it is an essential role that makes a significant difference in the person’s quality of life and outlook. For anyone who is providing caregiving for the first time, there are some key aspects to keep in mind.
The caregiver or caregivers’ role may vary, depending on the other support systems available to the person, and the physical needs of the patient. However, caregivers in general provide support to the person with the goal of easing some of the burdens, so that the patient can focus on their health needs.
What a Caregiver Provides
Some caregivers assist with practical matters, such as managing finances, legal and insurance issues, and coordinating medical appointments. A caregiver may be the person who joins the patient at doctor’s appointments, asking questions to familiarize themselves with the treatment options, and helping the patient in making informed decisions. A caregiver also provides emotional support, and helps the patient keep hope and strength as they undergo a serious life changing experience.
When a person takes on the role of a caregiver, they should be sensitive to the fact that they, too, will need support and self-care. Caring for a person with cancer or other serious illness is an emotional role, and the person providing care needs to recognize their own boundaries and capabilities.
It can be easy to become immersed in caring for a loved one and devoting large amounts of time and energy to their needs. But as cancer support groups know from experience, support for the caregiver as well is part of successfully balancing both person’s needs.
Support for Caregivers
Fortunately, there are numerous support groups and resources for both cancer patients and caregivers. Many nonprofit cancer research organizations, hospitals, cancer medical providers, and others, offer a variety of resources such as in-person and online support discussion groups. They have found that for the caregiver, there are general tips to help manage the role.
Getting care for one’s self and making time away from the caregiver role is important. Staying healthy by sticking with a routine of diet and exercise and taking breaks helps maintain normality.
The caregiver must also be ready to recognize that they alone cannot solve or manage everything for the patient. The patient ultimately is the one who is in -control, and it is psychologically healthy to allow them to make their own decisions – with support and input as they wish.
The caregiver will have understandable emotional ups and downs with their friend’s or loved one’s terminal cancer, and thus another good practice is to talk with others, whether professionally or otherwise. We often like to believe we can manage life stresses alone. But in reality, research has shown that support from others works.
Providing love and being present for someone undergoing illness can take a toll, so the best advice is to seek encouragement for yourself as a caregiver throughout the process as well.
Philadelphia Mesothelioma Lawyers at Brookman, Rosenberg, Brown & Sandler Will Fight for Mesothelioma Patients